Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 49, Issue 2, 2002, Pages 155-160

  Ueno, Hideki ^a   Okada, Shuichi ^a   Okusaka, Takuji ^a   Ikeda, Masafumi ^a   Kuriyama, Hitoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

5 Fluorouracil; Hepatocellular carcinoma; Pharmacokinetics; Phase I study

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; FLUOROURACIL;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG TOLERANCE; FEMALE; FEVER; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SEX DIFFERENCE; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0036158934     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-001-0400-8     Document Type: Article

References (29)

1. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors
2. Platinol (CDDP) and continuous intravenous infusion 5-fluorouracil in refractory stage IV breast cancer: A phase II study
3. Fluorouracil therapy in patients with carcinoma of the large bowel: A pharmacokinetic comparison of various rates and routes of administration
4. Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma
5. Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routes
6. Clinical pharmacology of 5-fluorouracil
7. Plasma pharmacokinetics of 5-FU given by continuous infusion with allopurinol
8. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma
9. No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day) 5-FU infusion
10. Clearance of continuously infused 5-fluorourauil in adults having lung or gastrointestinal carcinoma with or without hepatic metastases
11. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha
12. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program study
13. Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: A phase I, dose-finding study
14. Hepatic resection for hepatocellular carcinoma
15. Chemotherapy in hepatocellular carcinoma
16. A phase 2 study of cisplatin in patients with hepatocellular carcinoma
17. Predictive factors for postoperative recurrence of hepatocellular carcinoma
18. Early diagnosis of hepatocellular carcinoma
19. Toxicity and response criteria of the Eastern Cooperative Oneology Group
20. Mechanism for reduced drug clearance in patients with cirrhosis
21. Relative importance of dose, body surface area, sex, and age for 5-fluorouracil clearance
22. Effect of human renal and hepatic disease on the pharmacokinefics of anticancer drugs
23. Age sex are independent predictors of 5-fluorouracil toxicity
24. Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma
25. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma
26. A comparison of numerical integrating algorithms by trapezoidal, LaGrange, and spine approximation
27. Phase II trial of mitoxantrone in patients with hepatocellular carcinoma
28. Can pharmacokinetic monitoring improve clinical use of fluorouracil?